SLC16A12-AS1

Across TCGA pan-cancer cohorts, SLC16A12-AS1 RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated SLC16A12-AS1 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher SLC16A12-AS1 RNA is associated with better overall survival. In most high-consensus cancer types, elevated SLC16A12-AS1 expression acts as an unfavorable survival marker, although some lineages such as KIRC and MESO show a favorable association.

KIRC, MESO, and KIRP are the cancer types where SLC16A12-AS1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	OS	Tertile	All	0.710	0.524	<.001	124	view →
MESO	OS	Median	All	0.559	0.295	<.001	80	view →
KIRP	DFS	Median	All	0.938	0.595	<.001	72	view →
LUSC	OS	Tertile	IV	0.057	0.786	.017	42	view →
LUAD	OS	Tertile	All	0.561	0.280	.009	29	view →
LGG	DFS	Tertile	All	0.137	0.423	.018	12	view →
SKCM	DFS	Tertile	III,IV	0.156	0.600	.011	9	view →
ACC	OS	Tertile	III,IV	0.135	0.514	.020	9	view →
THCA	OS	Median	All	0.992	0.910	.018	7	view →
PAAD	DFS	Tertile	All	0.572	0.266	.048	6	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

SLC16A12-AS1–KIRC (OS)

Open the KIRC breakdown →